Referentielijst
Artikels 1. Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schroder, R., Deckert, M., Schmidt, S., Ravid, R., and Rajewsky, K. (2000). Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192, 393-404. 2. Beeson, P.B. (1994). Age and sex associations of 40 autoimmune diseases. Am. J. Med. 96, 457-462. 3. Ben-Nun, A., Wekerle, H., and Cohen, I.R. (1981). The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11, 195-199. 4. Booss, J., Esiri, M.M., Tourtellotte, W.W., and Mason, D.Y. (1983). Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62, 219-232. 5. Broekmans, T., Roelants, M., Alders, G., Feys, P., Thijs, H., and Eijnde, B.O. (2010). Exploring the effects of a 20-week whole-body vibration training programme on leg muscle performance and function in persons with multiple sclerosis. J. Rehabil. Med. 42, 866-872. 6. Calle, M.C., and Fernandez, M.L. (2010). Effects of resistance training on the inflammatory response. Nutr. Res. Pract. 4, 259-269. 7. Chiang, L.M., Chen, Y.J., Chiang, J., Lai, L.Y., Chen, Y.Y., and Liao, H.F. (2007). Modulation of dendritic cells by endurance training. Int. J. Sports Med. 28, 798-803. 8. Comabella, M., Montalban, X., Munz, C., and Lunemann, J.D. (2010). Targeting dendritic cells to treat multiple sclerosis. Nat. Rev. Neurol. 6, 499-507. 9. Confavreux, C., and Vukusic, S. (2006). Age at disability milestones in multiple sclerosis. Brain 129, 595-605. 10. Conraads, V.M., Beckers, P., Bosmans, J., De Clerck, L.S., Stevens, W.J., Vrints, C.J., and Brutsaert, D.L. (2002). Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease. Eur. Heart J. 23, 1854-1860. 11. Cools, N., Ponsaerts, P., Van Tendeloo, V.F., and Berneman, Z.N. (2007). Regulatory T cells and human disease. Clin. Dev. Immunol. 2007, 89195. 12. D'hooghe, M.B., Nagels, G., Bissay, V., and De, K.J. (2010). Modifiable factors influencing relapses and disability in multiple sclerosis. Mult. Scler. 16, 773-785. 13. Dalgas, U., Ingemann-Hansen, T., and Stenager, E. (2009). Physical Exercise and MS Recommendations. Int. MS J. 16, 5-11. 14. Ebers, G.C. (2008). Environmental factors and multiple sclerosis. Lancet Neurol. 7, 268-277. 15. Golzari, Z., Shabkhiz, F., Soudi, S., Kordi, M.R., and Hashemi, S.M. (2010). Combined exercise training reduces IFN-gamma and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis. Int. Immunopharmacol. 10, 1415-1419. 16. Heesen, C., Gold, S.M., Hartmann, S., Mladek, M., Reer, R., Braumann, K.M., Wiedemann, K., and Schulz, K.H. (2003). Endocrine and cytokine responses to standardized physical stress in multiple sclerosis. Brain Behav. Immun. 17, 473-481. 17. Hirose, L., Nosaka, K., Newton, M., Laveder, A., Kano, M., Peake, J., and Suzuki, K. (2004). Changes in inflammatory mediators following eccentric exercise of the elbow flexors. Exerc. Immunol. Rev. 10, 75-90. 18. Jennes, W., Kestens, L., Nixon, D.F., and Shacklett, B.L. (2002). Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15--the Amplispot assay. J. Immunol. Methods 270, 99-108. 19. Kurtzke, J.F. (1975a). A reassessment of the distribution of multiple sclerosis. Acta Neurol. Scand. 51, 137-157. 20. Kurtzke, J.F. (1975b). A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol. Scand. 51, 110-136. 21. Kurtzke, J.F. (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452. 22. Lancaster, G.I., Halson, S.L., Khan, Q., Drysdale, P., Wallace, F., Jeukendrup, A.E., Drayson, M.T., and Gleeson, M. (2004). Effects of acute exhaustive exercise and chronic exercise training on type 1 and type 2 T lymphocytes. Exerc. Immunol. Rev. 10, 91-106. 23. Lassmann, H., and Ransohoff, R.M. (2004). The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal. Trends Immunol. 25, 132-137. 24. McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland, H.F., Paty, D.W., Polman, C.H., Reingold, S.C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., van den Noort, S., Weinshenker, B.Y., and Wolinsky, J.S. (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121-127. 25. Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, N.A., Bogdan, C., Erb, K., Schuler, G., and Lutz, M.B. (2002). Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195, 15-21. 26. Moalem, G., Leibowitz-Amit, R., Yoles, E., Mor, F., Cohen, I.R., and Schwartz, M. (1999). Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5, 49-55. 27. Nieman, D.C. (1994). Exercise, infection, and immunity. Int. J. Sports Med. 15 Suppl 3, S131-S141. 28. Nuyts, A., Van Tendeloo, V.F., Van Camp, K., Lenders, K., Stein, B., Nagels, G., D'hooghe, M.B., Willekens, B., Berneman, Z.N., and Cools, N. (2011) Impairment of monocyt-derived dendritic cells to induce CD4+CD25hiFOXP3+ regulatory T cells in multiple sclerosis. Submitted for publication. 29. Oksenberg, J.R., Baranzini, S.E., Sawcer, S., and Hauser, S.L. (2008). The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet. 9, 516-526. 30. Pedersen, B.K., Akerstrom, T.C., Nielsen, A.R., and Fischer, C.P. (2007). Role of myokines in exercise and metabolism. J. Appl. Physiol 103, 1093-1098. 31. Rivera-Quinones, C., McGavern, D., Schmelzer, J.D., Hunter, S.F., Low, P.A., and Rodriguez, M. (1998). Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 4, 187-193. 32. Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C.R., Qin, S., and Lanzavecchia, A. (1998). Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769. 33. Schapiro, R.T.,Petajan, J.H., Kosich, D. (1988). Role of cardiovascular fitness in multiple sclerosis: a pilot study. J. Neurol. Rehabil. 2, 43-49. 34. Skulina, C., Schmidt, S., Dornmair, K., Babbe, H., Roers, A., Rajewsky, K., Wekerle, H., Hohlfeld, R., and Goebels, N. (2004). Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. U. S. A 101, 2428-2433. 35. Smith, L.L., Anwar, A., Fragen, M., Rananto, C., Johnson, R., and Holbert, D. (2000). Cytokines and cell adhesion molecules associated with high-intensity eccentric exercise. Eur. J. Appl. Physiol 82, 61-67. 36. Smith, R.M., Adeney-Steel, M., Fulcher, G., and Longley, W.A. (2006). Symptom change with exercise is a temporary phenomenon for people with multiple sclerosis. Arch. Phys. Med. Rehabil. 87, 723-727. 37. Snijders, A., Kalinski, P., Hilkens, C.M., and Kapsenberg, M.L. (1998). High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10, 1593-1598. 38. Stasiolek, M., Bayas, A., Kruse, N., Wieczarkowiecz, A., Toyka, K.V., Gold, R., and Selmaj, K. (2006). Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain 129, 1293-1305. 39. Steensberg, A., Fischer, C.P., Keller, C., Moller, K., and Pedersen, B.K. (2003). IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am. J. Physiol Endocrinol. Metab 285, E433-E437. 40. Stewart, L.K., Flynn, M.G., Campbell, W.W., Craig, B.A., Robinson, J.P., Timmerman, K.L., McFarlin, B.K., Coen, P.M., and Talbert, E. (2007). The influence of exercise training on inflammatory cytokines and C-reactive protein. Med. Sci. Sports Exerc. 39, 1714-1719. 41. Suchanek, O., Podrazil, M., Fischerova, B., Bocinska, H., Budinsky, V., Stejskal, D., Spisek, R., Bartunkova, J., and Kolar, P. (2010). Intensive physical activity increases peripheral blood dendritic cells. Cell Immunol. 266, 40-45. 42. Tremlett, H., Zhao, Y., Joseph, J., and Devonshire, V. (2008). Relapses in multiple sclerosis are age- and time-dependent. J. Neurol. Neurosurg. Psychiatry 79, 1368-1374. 43. Van Brussel, I., Van Vre, E.A., De Meyer, G.R., Vrints, C.J., Bosmans, J.M., and Bult, H. (2011). Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function. Clin. Sci. (Lond) 120, 415-426 44. Venken, K., Hellings, N., Hensen, K., Rummens, J.L., Medaer, R., D'hooghe, M.B., Dubois, B., Raus, J., and Stinissen, P. (2006). Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J. Neurosci. Res. 83, 1432-1446. 45. White, L.J., and Castellano, V. (2008). Exercise and brain health--implications for multiple sclerosis: Part II--immune factors and stress hormones. Sports Med. 38, 179-186. 46. White, L.J., Castellano, V., McCoy, S. (2006). Cytokine changes after a resistance training program in multiple sclerosis patients. J. Sport. Sci. 24, 1-4. 47. Wingerchuk, D.M., Lucchinetti, C.F., and Noseworthy, J.H. (2001). Multiple sclerosis: current pathophysiological concepts. Lab Invest 81, 263-281. Boeken1. Abbas, A.K., Lichtman, A.H., and Pillai S. (2007). Cellular and Molecular Immunology. 6th edition (Philadelphia: Saunders Elsevier).